From October 23 to 25, 2019, 4th China Pharma IP Summit was held in Shanghai. Prof. Song Xiaoting, Associate Prof. Cao Lirong and doctoral candidates from SICIP of Tongji University were invited to attend the seminar. Prof. Song Xiaoting made a special report on "Technical Protection of Traditional Chinese Medicine: Opportunities and Challenges" and presided over a special discussion.

Prof. Song Xiaoting gave a speech at the summit

Prof. Song Xiaoting made a systematic exposition of the international environment and historical opportunities faced by Chinese pharmaceutical enterprises and responded to questions from enterprises. Discussed with representatives from Tasly Holding Group Co., Ltd., Shineway Pharmaceutical Group Co., Ltd., Yabao Pharmaceutical Group Co., Ltd. and Shijiazhuang Yiling Pharmaceutical Co., Ltd on relative issues.

Background of this Pharma Intellectual Property Summit is the fourth revision of Chinese Patent Law, changes in intellectual property policies at home and abroad, and opportunities and challenges under global pharmaceutical innovation.

Translated by Kai Yang